Miracco C, Toscano M, Butorano M, Baldino G, Tacchini D, Barone A, et al. Unusual clear cell, lymphoplasmacyte-rich, dural-based tumor with divergent differentiation: a tricky case mimicking a meningioma. Hum Pathol. 2015;46:1050-6 pubmed publisher

WALSH E, Shalaby A, O Loughlin M, Keane N, Webber M, Kerin M, et al. Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy. Breast Cancer Res Treat. 2019;174:1-13 pubmed publisher

Engels C, Fontein D, Kuppen P, de Kruijf E, Smit V, Nortier J, et al. Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma. Br J Cancer. 2014;111:532-8 pubmed publisher

Konsti J, Lundin M, Linder N, Haglund C, Blomqvist C, Nevanlinna H, et al. Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium. Diagn Pathol. 2012;7:29 pubmed publisher

Linder N, Konsti J, Turkki R, Rahtu E, Lundin M, Nordling S, et al. Identification of tumor epithelium and stroma in tissue microarrays using texture analysis. Diagn Pathol. 2012;7:22 pubmed publisher

Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimaki A, Holli K, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res. 2011;13:R87 pubmed publisher

BOCKELMAN C, Lassus H, Hemmes A, Leminen A, Westermarck J, Haglund C, et al. Prognostic role of CIP2A expression in serous ovarian cancer. Br J Cancer. 2011;105:989-95 pubmed publisher

Gulati S, Ytterhus B, Granli U, Gulati M, Lydersen S, Torp S. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas. Diagn Pathol. 2010;5:18 pubmed publisher